[Psychopharmacotherapy and internal medicine].
The application of psychopharmacotherapy is admissable only after diagnostic clarification. Run-in period of tricyclic antidepressive agents and highly potent neuroleptic agents are to be taken into consideration, use low-potent neuroleptic drugs for rapid relaxation. At first always exhaust monotherapy, instead of application of tranquilizers application of low-dose neuroleptic agents for permanent therapy. Using small initial doses and gradually increasing to optimum amounts is to be preferred for the establishment of the individual disposition. When a danger of habit formation is existing neuroleptic drugs are to be preferred. In all psychoreactive disturbances at first ventilate psychotherapy [5], only then prescription of remedies in the basic psychotherapeutic concept. The patients must be comprehensively informed about the aim of the treatment, the effects and side-effects and the fitness for driving, when being under psychopharmacotherapy.
Härtel
F
F
Zentralen Klinik für Neurologie/Psychiatrie, Wiesenburg des MVB Wismut Zwickau.
D006801:Humans; D007388:Internal Medicine; D001523:Mental Disorders / Q000188:drug therapy*; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*
D011619:Psychotropic Drugs
Psychopharmakotherapie und internistische Praxis.